Bibliografisk träff 2011-03-07 Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins. Fleischer JG, Rossignol D, Francis GA, Chan T, Lynn M, Wasan KM. Innate Immun · research support, non-u.s. gov't; journal article · DOI 10.1177/1753425910394395
Bibliografisk träff 2008-02-29 Eritoran: the evidence of its therapeutic potential in sepsis. Raja SG, Dreyfus GD. Core Evid · review-article; journal article · DOI 10.2147/ce.s7430